International IPO

International IPO

Sleep Apnea Drug Developer Apnimed Files for Nasdaq IPO Following FDA Acceptance

Clinical-stage biotechnology firm Apnimed has submitted its S-1 prospectus for a Nasdaq IPO following FDA acceptance of its New Drug Application for sleep apnea oral treatment Oxnimbi.

London Stock Exchange LSE IPO Listings Cover

International IPO

London Stock Market Bounces Back with New Beauty and Consumer Brand IPO Listings

The London Stock Exchange (LSE) is showing signs of recovery in listing activity, with a major beauty group and a consumer brand confirming prospectus filings for the second half of 2026.

International IPO

OpenAI Files Confidentially for Initial Public Offering on US Stock Market

Artificial intelligence pioneer OpenAI has reportedly filed confidential draft papers for a US initial public offering (IPO), targeting listing gains and seeking capital to fund massive AGI infrastructure.